The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives

Blood - Tập 119 Số 14 - Trang 3321-3329 - 2012
Steven H. Bernstein1, Sundararajan Venkatesh2, Min Li2, Jae Lee2, Bin Lü2, Shannon P. Hilchey1, Kimberly Morse1, Hollie M. Metcalfe1, Jolanta Skalska1, Michael Andreeff3, Paul S. Brookes4, Carolyn K. Suzuki2
1James P. Wilmot Cancer Center; University of Rochester Medical Center, Rochester, NY
2Department of Biochemistry and Molecular Biology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ;
3Molecular Hematology and Therapy, MD Anderson Cancer Center, Houston, TX; and
4Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY

Tóm tắt

Abstract Synthetic triterpenoids are multitarget compounds exhibiting promise as preventative and therapeutic agents for cancer. Their proposed mechanism of action is by forming Michael adducts with reactive nucleophilic groups on target proteins. Our previous work demonstrates that the 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and its derivatives promote B-lymphoid cell apoptosis through a mitochondria-mediated pathway linked to mitochondrial protein aggregation. As one function of the Lon protease is to eliminate abnormal mitochondrial proteins, we hypothesized that CDDO-induced protein aggregation and lymphoma apoptosis occur by inactivating this enzyme. Here, we show that CDDO and its derivatives directly and selectively inhibit Lon. CDDO blocks Lon-mediated proteolysis in biochemical and cellular assays, but does not inhibit the 20S proteasome. Furthermore, a biotinylated-CDDO conjugate modifies mitochondrial Lon. A striking common phenotype of CDDO-treated lymphoma cells and Lon-knockdown cells is the accumulation of electron-dense aggregates within mitochondria. We also show that Lon protein levels are substantially elevated in malignant lymphoma cells, compared with resting or activated B cells. Finally, we demonstrate that Lon knockdown leads to lymphoma cell death. Together, these findings suggest that Lon inhibition plays a contributory role in CDDO-induced lymphoma cell death, and support the concept that mitochondrial Lon is a novel anticancer drug target.

Từ khóa


Tài liệu tham khảo

Dai, 2007, Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis., Cell, 130, 1005, 10.1016/j.cell.2007.07.020

Leu, 2009, A small molecule inhibitor of inducible heat shock protein 70., Mol Cell, 36, 15, 10.1016/j.molcel.2009.09.023

Trepel, 2010, Targeting the dynamic HSP90 complex in cancer., Nat Rev Cancer, 10, 537, 10.1038/nrc2887

Banerji, 2005, Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies., J Clin Oncol, 23, 4152, 10.1200/JCO.2005.00.612

Hanahan, 2000, The hallmarks of cancer., Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Luo, 2009, Principles of cancer therapy: oncogene and non-oncogene addiction., Cell, 136, 823, 10.1016/j.cell.2009.02.024

Venkatesh, 2012, Multitasking in the mitochondrion by the ATP-dependent Lon protease., Biochim Biophys Acta, 1823, 56, 10.1016/j.bbamcr.2011.11.003

Lee, 2008, Functional mechanics of the ATP-dependent Lon protease- lessons from endogenous protein and synthetic peptide substrates., Biochim Biophys Acta, 178, 727, 10.1016/j.bbapap.2008.02.010

Bota, 2001, Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders., Mitochondrion, 1, 33, 10.1016/S1567-7249(01)00005-8

Fukuda, 2007, HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells., Cell, 129, 111, 10.1016/j.cell.2007.01.047

Hori, 2002, Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon protease., J Cell Biol, 157, 1151, 10.1083/jcb.200108103

Koumenis, 2006, ER stress, hypoxia tolerance and tumor progression., Curr Mol Med, 6, 55, 10.2174/156652406775574604

Bayot, 2010, Identification of novel oxidized protein substrates and physiological partners of the mitochondrial ATP-dependent Lon-like protease Pim1., J Biol Chem, 285, 11445, 10.1074/jbc.M109.065425

Bender, 2010, The role of protein quality control in mitochondrial protein homeostasis under oxidative stress., Proteomics, 10, 1426, 10.1002/pmic.200800619

Bota, 2002, Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism., Nat Cell Biol, 4, 674, 10.1038/ncb836

Liby, 2007, Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer., Nat Rev Cancer, 7, 357, 10.1038/nrc2129

Ahmad, 2006, Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179., J Biol Chem, 281, 35764, 10.1074/jbc.M607160200

Ahmad, 2008, Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)–>signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3., Cancer Res, 68, 2920, 10.1158/0008-5472.CAN-07-3036

Wang, 2000, A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma., Mol Endocrinol, 14, 1550

Couch, 2005, Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action., Bioorg Med Chem Lett, 15, 2215, 10.1016/j.bmcl.2005.03.031

Samudio, 2005, 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer., J Biol Chem, 280, 36273, 10.1074/jbc.M507518200

Samudio, 2006, A novel mechanism of action of methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate: direct permeabilization of the inner mitochondrial membrane to inhibit electron transport and induce apoptosis., Mol Pharmacol, 69, 1182, 10.1124/mol.105.018051

Samudio, 2008, Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells., Mol Cancer Ther, 7, 1130, 10.1158/1535-7163.MCT-07-0553

Ikeda, 2003, The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance., Cancer Res, 63, 5551

Brookes, 2007, The triterpenoid CDDO and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore., Cancer Res, 67, 1793, 10.1158/0008-5472.CAN-06-2678

Couch, 2006, 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosis., Mol Pharmacol, 69, 1158, 10.1124/mol.105.018572

Kress, 2007, Triterpenoids display single agent antitumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma., PLoS One, 2, e559, 10.1371/journal.pone.0000559

Ray, 2006, The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway., Exp Hematol, 34, 1201, 10.1016/j.exphem.2006.04.026

Lu, 2007, Roles for the human ATP-dependent Lon protease in mitochondrial DNA maintenance., J Biol Chem, 282, 17363, 10.1074/jbc.M611540200

King, 1996, Isolation of human cell lines lacking mitochondrial DNA., Methods Enzymol, 264, 304, 10.1016/S0076-6879(96)64029-4

Lu, 2003, The ATP-dependent Lon protease of Mus musculus is a DNA-binding protein that is functionally conserved between yeast and mammals., Gene, 306, 45, 10.1016/S0378-1119(03)00403-7

Liu, 2004, DNA and RNA binding by the mitochondrial Lon protease is regulated by nucleotide and protein substrate., J Biol Chem, 279, 13902, 10.1074/jbc.M309642200

Ondrovicova, 2005, Cleavage Site Selection within a Folded Substrate by the ATP-dependent Lon Protease., J Biol Chem, 280, 25103, 10.1074/jbc.M502796200

Diefenbach, 2010, Mantle cell lymphoma in relapse: the role of emerging new drugs., Curr Opin Oncol, 22, 419, 10.1097/CCO.0b013e32833d58f2

Matsushima, 2010, Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM)., Proc Natl Acad Sci U S A, 107, 18410, 10.1073/pnas.1008924107

Larsson, 1994, Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion., Biochem Biophys Res Commun, 200, 1374, 10.1006/bbrc.1994.1603

Seidel-Rogol, 2002, Modulation of mitochondrial transcription in response to mtDNA depletion and repletion in HeLa cells., Nucleic Acids Res, 30, 1929, 10.1093/nar/30.9.1929

Frase, 2006, Identification of the proteasome inhibitor MG262 as a potent ATP-dependent inhibitor of the salmonella enterica serovar typhimurium Lon protease., Biochemistry, 45, 8264, 10.1021/bi060542e

Granot, 2007, Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors., Mol Endocrinol, 21, 2164, 10.1210/me.2005-0458

Honda, 2004, Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets., J Med Chem, 47, 4923, 10.1021/jm049727e

Suzuki, 1994, Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration., Science, 264, 273, 10.1126/science.8146662

Simpson, 2010, High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance., Cancer Res, 70, 8446, 10.1158/0008-5472.CAN-10-1590

Virrey, 2008, Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells., Mol Cancer Res, 6, 1268, 10.1158/1541-7786.MCR-08-0060

Zhu, 2002, Epidermal growth factor up-regulates the transcription of mouse lon homology ATP-dependent protease through extracellular signal-regulated protein kinase- and phosphatidylinositol-3-kinase-dependent pathways., Exp Cell Res, 280, 97, 10.1006/excr.2002.5621

Luciakova, 1999, Enhanced mitochondrial biogenesis is associated with increased expression of the mitochondrial ATP-dependent Lon protease., FEBS Lett, 444, 186, 10.1016/S0014-5793(99)00058-7

Bota, 2005, Down-regulation of the human Lon protease impairs mitochondrial structure and function and causes cell death., Free Radic Biol Med, 38, 665, 10.1016/j.freeradbiomed.2004.11.017

Dong, 2008, Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development., Cancer Res, 68, 498, 10.1158/0008-5472.CAN-07-2950

Tew, 2010, Redox platforms in cancer drug discovery and development., Curr Opin Chem Biol, 15, 156, 10.1016/j.cbpa.2010.10.016

Trachootham, 2009, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat Rev Drug Discov, 8, 579, 10.1038/nrd2803

Biasutto, 2010, Mitochondrially targeted anticancer agents., Mitochondrion, 10, 670, 10.1016/j.mito.2010.06.004